During the annual American Association for the Advancement of Science meeting on Thursday in Boston, AAAS President David Baltimore said scientists are no closer to developing an HIV vaccine than they were when vaccine research began, BBC News reports (Briggs, BBC News, 2/15).

Baltimore, a biology professor at the California Institute of Technology, said some scientists have begun to openly discuss the possibility of never developing an HIV vaccine because of the virus’s ability to weaken the body’s immune system while it progresses to AIDS (Connor, Independent, 2/15). “This is a huge challenge because to control HIV immunologically, the scientific community has to beat out nature,” Baltimore said (BBC News, 2/15).

Baltimore added that the HIV vaccine development community is “depressed” after recent failed attempts to develop a vaccine but said that will not halt HIV vaccine research. The HIV vaccine community needs to begin “thinking about [vaccine development] in a very different way,” he said, adding that scientists are beginning “trendy and difficult” research involving gene therapy, immunotherapy and stem cell therapy (Independent, 2/15). He added that researchers are trying to “design vectors that can carry genes that will be of therapeutic advantage” (BBC News, 2/15).

Baltimore said he is not “prepared” to say that an HIV vaccine will never be developed because he does not want to “take a pessimistic stance. I want to take an optimistic stance and say this is too important to give up on” (Independent, 2/15).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2007 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Changes in the distribution of Ryan White Program money are creating funding shortages for Southern California-based AIDS groups, the Riverside Press-Enterprise reports. According to San Bernardino County, Calif., health officials, about 7,400 people are living with HIV/AIDS in San Bernardino and Riverside counties (McGavin, Riverside Press-Enterprise, 2/14).

Congress in December 2007 reauthorized Ryan White to allow funding in more regions but less money for support programs — including meals, housing and legal aid. In addition, Ryan White funding during the past several years has remained at about $2.1 billion annually, but more HIV-positive people are seeking treatment and living longer (Kaiser Daily HIV/AIDS Report, 8/2/07).

According to the Press-Enterprise, AIDS groups in Southern California have “scrambled” for funding in the past year, as requests for assistance have increased. The Inland AIDS Project received about $711,000 in 2007 from the Ryan White Program, down from about $1 million the previous year. Joy Gould, CEO of IAP, said that funding for food vouchers declined the most, from about $100,000 to less than $40,000. She added, “This last year has been the most difficult year we’ve ever had.” IAP provides food vouchers, transportation, case management and other help to more than 1,300 people living with HIV/AIDS in Riverside and San Bernardino counties.

Daniel Perez — a program manager with the San Bernardino County Department of Public Health, which distributes federal funds to about six providers in the region — said this year’s changes to the Ryan White Program are the “most drastic” since the legislation was enacted in 1990. As a result of the changes, 75% of funds must go toward medical, substance abuse and other services, and no more than 25% can be allotted to food vouchers, transportation and case management, Perez added.

David Brinkman, executive director of the Palm Springs, Calif.-based Desert AIDS Project, said the organization “saw a 25% increase in the number of patients in the last 12 months.” He added, “We are forced to do more with less [money], and we’re forced to go to our private donor community and ask for more. It’s a huge strain” (Riverside Press-Enterprise, 2/14).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2007 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

The U.S. State Department on Friday removed HIV from a list of medical conditions that automatically disqualify people from entering the Foreign Service, the AP/Google.com reports. According to the state department, Foreign Service candidates living with HIV now will be considered for positions on a case-by-case basis — similar to candidates who have other illnesses, such as cancer — to determine whether they are eligible for “worldwide availability.”

The policy change comes less than two weeks before a trial in a lawsuit involving an HIV-positive man who was rejected by the Foreign Service despite his qualifications, the AP/Google.com reports. The lawsuit was filed in 2003 by Lorenzo Taylor, a trilingual international affairs specialist. Taylor passed the Foreign Service exam process but was denied when he revealed his HIV-positive status to the state department.

According to the state department, the policy was changed after consultation with medical experts and in response to the lawsuit. However, the department maintained that the policy never purposefully discriminated against HIV-positive people. The state department also noted that the previous policy had applied only to Foreign Service candidates, not those who had contracted the virus or other conditions during their tours, the AP/Google.com reports.

“We have a policy requiring that all Foreign Service officers be worldwide available as determined by a medical examination at the time of entry into the Foreign Service,” Gonzalo Gallegos, a state department spokesperson, said, adding, “That has not changed.” Gallegos said that the department’s chief medical officer had “revised its medical clearance guidelines on HIV based on advances in HIV care and treatment and consultations with medical experts. The new clearance guidelines provide that HIV-positive individuals may be deemed worldwide available if certain medical conditions are met.”

Taylor said in a statement, “Now people like me who apply to the Foreign Service will not have to go through what I did.” He added, “They and others with HIV will know that they do not have to surrender to stigma, ignorance, fear or the efforts of anyone, even the federal government, to impose second-class citizenship on them. They can fight back.” New York-based Lambda Legal — which represented Taylor and advocates for homosexuals, bisexuals, transgender people and HIV-positive people — applauded the change. “The new guidelines mean that candidates for Foreign Service posts who have HIV will now be assessed on a case-by-case basis, as the law requires,” Bebe Anderson, the organization’s HIV project director, said, adding, “At long last, the state department is taking down its sign that read, ‘People with HIV need not apply.’”

Lambda Legal said the suit has been settled “partly due to the new guidelines.” However, the state department said the policy change was not part of the settlement. “The change simply reflects medical advances in the area of HIV care and maintenance,” Gallegos said (Lee, AP/Google.com, 2/16).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2007 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

President Bush on Sunday during a trip to Tanzania called on Congress to quickly reauthorize the President’s Emergency Plan for AIDS Relief, the New York Times reports (Gay Stolberg, New York Times, 2/18). Bush and first lady Laura Bush are on a five-country tour of Africa in part to highlight programs funded by PEPFAR and the President’s Malaria Initiative (Kaiser Daily HIV/AIDS Report, 2/15).

PEPFAR initially was authorized to direct $15 billion over five years for HIV/AIDS and tuberculosis primarily to 15 focus countries. Bush in May 2007 called on Congress to increase this initial PEPFAR funding level to $30 billion for five years after the program’s original mandate expires in September 2008 (Kaiser Daily HIV/AIDS Report, 1/29). Bush on Sunday criticized Democratic-proposed changes to PEPFAR and urged lawmakers to “listen to leaders on the continent of Africa, analyze what works, stop the squabbling and get the program reauthorized.” Bush added that he thinks the “current policy is reasonable” and that “it’s working” (Loven, AP/San Jose Mercury News, 2/17).

PEPFAR is a “balanced program,” Bush said, adding, “It is an ABC program: abstinence, be faithful and condoms. It’s a program that’s been proven effective.” He said that it is in U.S. “national interest” to address HIV/AIDS and related problems in Africa.

Laura Bush in response to critics who have proposed reauthorizing PEPFAR at $50 billion said focus countries do not have the resources to handle that large of an amount efficiently, adding that “for budget reasons” the program “should stay at $30 billion” (Gerstenzang, Los Angeles Times, 2/18). Tanzanian President Jakaya Kikwete said that “[d]ifferent people may have different views about” Bush, his administration and his “legacy” but that the Bush administration has “been good friends of [Tanzania] and have been good friends of Africa.”

Bush and Kikwete both declined to answer questions about the upcoming U.S. presidential election and the campaign of Sen. Barack Obama (D-Ill.), who is black and whose father is from Kenya. Kikwete said the “most important thing” for Tanzania regarding the next U.S. president is that he or she is a “good friend of Africa as President Bush has been” (Baker, Washington Post, 2/18).

Bush and Kikwete on Sunday signed a $698 million Millennium Challenge Account aid package to the country, which will be used for clean-water projects, hydropower development and to improve infrastructure, the Washington Times reports. Bush during the signing ceremony said Tanzania was receiving the grant, the largest awarded by the program to date, because the Tanzanian government is “committed to honest, decent government for the people” (Ward, Washington Times, 2/18).

After leaving Tanzania, the Bushes traveled to Rwanda, where Bush met with Rwandan President Paul Kagame and was scheduled to visit an HIV/AIDS project (Charles/Asiimwe, Reuters, 2/19). The president and first lady also visited Benin during their trip, the Times reports (Gerstenzang, Los Angeles Times, 2/17).

Broadcast Coverage
Several broadcast programs reported on the Bushes’ trip to Africa. Summaries appear below.

• “Ask the White House”: Laura Bush is scheduled to discuss the trip Wednesday at 1:30 p.m. ET in an “Ask the White House” online chat (”Ask the White House” Web site, 2/19). Questions can be submitted online before the chat. A transcript will be available online after the chat.
  
  
• ABC’s “World News”: The program on Sunday reported on Bush’s popularity in Africa. The segment includes comments from Bush and Kikwete (Hendren, “World News,” ABC, 2/17). Video of the segment and expanded ABC News coverage are available online.
  
  
• NBC’s “Nightly News”: The program on Sunday profiled Evelyn Katabizi, an HIV-positive girl in Uganda whose mother died of AIDS-related causes. The segment includes comments from Katabizi (Fletcher, “Nightly News,” NBC, 2/17). Video of the segment is available online. On Monday, the program reported on a foster home in Uganda for AIDS orphans. The segment includes comments from Nolena Nemukeza, founder of the foster home, and Stephanie Robertson of the U.S. Peace Corps (Fletcher, “Nightly News,” NBC, 2/18). Video of the segment is available online. Expanded NBC News coverage is available online.
  
  
• NBC’s “Today”: The segment includes a discussion with the Bushes about the trip and other topics (Curry, “Today,” NBC, 2/18). Video of the segment is available online.
  
  
• NPR’s “Morning Edition”: The program on Monday reported on the Bushes’ trip to Tanzania. The segment includes comments from U.S. Global AIDS Coordinator Mike Dybul and Bush (Thompkins, “Morning Edition,” NPR, 2/18). Audio of the segment is available online.
  
  
• NPR’s “Weekend Edition Saturday”: The segment includes a discussion with Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, about PEPFAR (Simon, “Weekend Edition Saturday,” NPR, 2/17). Audio of the segment is available online.
  
  
• NPR’s “Weekend Edition Sunday”: The segment includes a discussion with NPR correspondent Gwen Thompkins about the Bushes’ trip (Hansen, “Weekend Edition Sunday,” NPR, 2/18). Audio of the segment is available online.

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2007 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

During a news conference in Dar es Salaam, Tanzania, Sunday, President Bush called on Congress to quickly reauthorize his global HIV/AIDS program and keep intact a provision that requires one-third of HIV prevention funding be spent on abstinence-only education, the New York Times reports (Stolberg, New York Times, 2/18).

According to the Los Angeles Times, an Institute of Medicine report and a Government Accountability Office report have said the strong focus on abstinence in the President’s Emergency Plan for AIDS Relief has limited the program’s reach. “It is a balanced program,” Bush said during a news conference with Tanzanian President Jakaya Kikwete, adding, “It is an ABC program: abstinence, be faithful and condoms. It’s a program that’s been proven effective” (Gerstenzang, Los Angeles Times, 2/18).

Bush is requesting PEPFAR be given $30 billion in funding over the next five years. “I understand there’s voices on both ends of the political spectrum trying to alter the program,” Bush said, adding, “I would ask Congress to listen to leaders on the continent of Africa, find — analyze what works, stop the squabbling and get the program reauthorized” (Baker, Washington Post, 2/18).

A draft bill in the House Foreign Affairs Committee includes changes that would remove the abstinence-only education requirement from PEPFAR. The draft bill also includes new language that would strengthen support for contraceptive services for the purpose of augmenting the HIV prevention effort, as well as remove a requirement that groups receiving PEPFAR funds adopt a policy position opposing prostitution.

Some congressional Republicans oppose the changes. However, former House Foreign Affairs Committee Chair Tom Lantos (D-Calif.), who died last week, has said that the Democrats’ proposed changes to the program would reaffirm a compromise Republicans and Democrats made when they approved the original PEPFAR bill in 2003 (Daily Women’s Health Policy Report, 2/8).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women’s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women’s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2007 The Advisory Board Company. All rights reserved.

On 22nd February at 12.30pm HIV & sexual health charity Terrence Higgins Trust (THT), will be officially opening its new centre in Birkenhead which will serve the whole of the Wirral.

The opening will be attended by celebrity supporter Claire Sweeney, the Mayor of Wirral, Councillor Phil Gilchrist and the Chairman of Wirral Primary Care Trust, Frances Street. It will be an opportunity for clients, partner agencies and other interested parties to meet THT staff and members of the Executive Team to discuss plans for services in the area.

The new office, funded by Wirral Primary Care Trust will provide a range of services:

-Health promotion outreach work focused on preventing HIV from being passed on
-Support groups and health advice for people affected by HIV and sexual ill health
-One to one support
-General information on sexually transmitted infections
-Condoms and safer sex information
-Counselling
-Raising sexual health awareness through training and education

Representatives from the NHS and social services, other voluntary organisations, THT volunteers and staff will all be attending the open day.

Ewan Jenkins, Manager of the new office said “We’re delighted to be opening an office here in the Wirral. We’re looking forward to working with other organisations in the region to increase awareness of sexual health and support people who are living with HIV in the area.”

Notes

-The photocall will take place at 1pm on 22 February at:

Terrence Higgins Trust
5 Bridge Street
Birkenhead
Wirral
CH41 1AS

-There were 492 new diagnoses of HIV in the North West in 2007. 4,512 people were accessing HIV care services in the region. Approximately a third of people with HIV in the North West remain undiagnosed.

-Terrence Higgins Trust is the UK’s leading HIV and sexual health charity, providing a wide range of services across England, Wales and Scotland. The charity also campaigns and lobbies for greater political and public understanding of the personal, social and medical impact of HIV and sexual ill health.

Terrence Higgins Trust

UNISON, the UK’s largest public sector union, is calling on NHS Employers to banish the agony of needlestick injuries (NSI) for good, by making safer needles compulsory across the health service. The call comes in the wake of the tragic death of gifted nurse, Juliet Young, who contracted HIV from a needlestick injury while working at the Maudsley Mental Health Hospital in London.

Karen Jennings, UNISON Head of Health, said:

“Juliet Young’s death is a tragedy, made sadder still, because it was preventable and our hearts go out to her family. Safer needles are available and Juliet’s death begs the question - how many more people have to die before NHS Employers make safer needles compulsory throughout the NHS?

“We need accurate data to assess the extent of the NSI problem but estimates put the number of injuries as high as 100,000 every year. Each one puts the person affected through months, sometimes years of agony. I have no doubt that news of Juliet’s death will add to their fear and misery, as they go through all the tests and treatment necessary following a needlestick injury.

“The European Commission is currently looking at Europe wide legislation on safer needles. If safer needles were made compulsory across Europe there would be economies of scale that would bring down the cost of safer devices benefiting everyone.”

Notes

The UK Health Protection Agency latest statistics show that reported exposures in the UK to blood borne viruses (HIV, Hep C & Hep B) in healthcare settings caused by percutaneous injuries have increased by nearly 50% from 206 in 2002 to 306 in 2007. These figures are only the tip of the iceberg. Although the number of reported NSI in UK are not collected centrally, estimates (including unreported incidents) put their number as high as 100,000.

The only official figures in the UK come from the results of a survey published by NHS Scotland of the 28 Scottish trusts, conducted between 1996 and 1999. This revealed a total of 6811 reported NSI in the period in question. The same report also said that unreported incidents meant this figure may only account for as little as 30% of the actual total, that NSI cost NHS Scotland ￡78,682 per year, and that the use of safer needles would reduce this figure by 60%.

UNISON

UCL (University College London) scientists have taken a significant step in understanding how retroviruses such as HIV can move between species and the biological mechanisms behind the ‘jumping genes’ which make some monkeys immune. They will now use this knowledge to develop a gene therapy treatment for HIV/AIDS in humans.

The international team of researchers, coordinated by Professor Greg Towers, UCL Infection and Immunity, and funded by the Wellcome Trust, have identified a combination of genes in a species of monkey that protects against retroviruses - a particularly opportunistic family of viruses that can integrate into the host’s genome and replicate as part of the cell’s DNA. The team’s findings are published today in Proceedings of the National Academy of Sciences (PNAS).

Professor Towers explained: “HIV causes AIDS and affects around 40 million people worldwide. Research has shown that HIV entered the human population from a chimpanzee retrovirus called SIV early in the 20th century. In order for a virus to successfully cross the species barrier and jump into a new species, it first has to bypass the new host’s innate immune system, mediated by a combination of genes and proteins. One such gene, called TRIM5, has been shown to protect certain species from retroviruses - but unfortunately the human TRIM5 gene does not protect against HIV infection.”

The team found that a species of Asian monkey called Rhesus Macaques have a sophisticated ‘antiviral arsenal’ that can protect them against retroviruses. By closely examining TRIM5 in this species, they demonstrate that in some monkeys another gene called Cyclophilin has been joined to the TRIM5 gene, generating a TRIMCyp fusion.

Dr Sam Wilson, the paper’s first author, said: “Cyclophilin is very good at grabbing viruses as they enter cells. By fusing Cyclophilin to TRIM5, a gene is made that is good at grabbing viruses and good at destroying them. This is the second time that this fusion has been identified - a TRIMCyp gene also exists in South American Owl Monkeys and, until now, this was thought to be an evolutionary one-off.

“This new research shows that a TRIMCyp has evolved independently in two separate species - it’s like lightening has struck twice. It’s a remarkable example of convergent evolution, where organisms independently evolve similar traits as a result of having to adapt to similar environments. It also highlights the evolutionary selection pressure that viruses like HIV can apply.”

Professor Greg Towers explained further: “The discovery is a compelling example of how ‘jumping genes’ can shuffle an organism’s genetic makeup, generating useful new genes, and it is an exciting possibility for novel treatments for HIV/AIDS.

“About 25 per cent of Rhesus Macaques have the TRIM5 and a TRIMCyp gene, greatly expanding their antiviral arsenal. The others have an immunity, based around TRIM5, that protects them against a different combination of viruses. The gene seems to be evolving to protect the individual species from a range of different virus sequences.”

Professor Towers and his team now aim to develop humanised TRIMCyp that blocks HIV infection by artificially fusing human Cyclophilin and human TRIM5. Professor Towers said: “We can then introduce the TRIMCyp into stem cells, using gene therapy technologies, and the stem cells could repopulate the patient with blood cells that are immune to HIV. This work, already underway, could offer a real possibility of novel treatments for HIV/AIDS.”

Notes

1. ‘Independent evolution of an antiviral TRIMCyp in Rhesus Macaques’ is published in the journal PNAS and is embargoed to 22:00 UK time (17:00 US Eastern) Monday 18 February 2008. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.

2. Images of Rhesus Macaques can be obtained from the UCL Media Relations Office.

3. Funding for this study came from The Wellcome Trust. The Medical Research Council also provide core funding for the MRC Centre for Medical Molecular Virology at UCL.

4. The study was carried out by researchers at the MRC Centre for Medical Molecular Virology at UCL, the Biomedical Primate Research Centre, Rijswijk, The Netherlands, and the Department of Veterinary Medicine, Cambridge University.

About UCL

Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government’s most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence.

UCL is in the top ten world universities in the 2007 THES-QS World University Rankings, and the fourth-ranked UK university in the 2007 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Marie Stopes, Jonathan Dimbleby, Lord Woolf, Alexander Graham Bell, and members of the band Coldplay.

University College London

About the Wellcome Trust

The Wellcome Trust is the largest charity in the UK. It funds innovative biomedical research, in the UK and internationally, spending around ￡500 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and wellbeing.

Wellcome Trust

The U.S. effort to fight HIV/AIDS in Africa is “work of healing and redemption” and is a “wise exercise of American influence,” President Bush said Thursday during a speech at the Smithsonian National Museum of African Art in Washington, D.C., USA Today reports. “The changes taking place in Africa don’t always make the headlines,” Bush said, adding, “The work is quiet, but it is not thankless” (Wolf, USA Today, 2/15).

Bush delivered his speech a day before he and first lady Laura Bush take a five-country tour of Africa in part to highlight programs funded by the President’s Emergency Plan for AIDS Relief and the President’s Malaria Initiative, the Wall Street Journal reports. The president likely will highlight his PEPFAR reauthorization request while on the tour, according to the Journal (McKinnon, Wall Street Journal, 2/15).

The president and Laura Bush will begin their trip in Benin. They plan to meet with Benin’s President Thomas Yayi to discuss the progress of PMI and Millennium Challenge Corporation programs in the country. The Bushes then are scheduled to visit Tanzania. They plan to visit several facilities in Arusha, Tanzania, including a factory that manufactures insecticide-treated nets for the prevention of malaria. In addition, the president will participate in a discussion about PEPFAR programs in the country. Bush and the first lady will then travel to Rwanda, Ghana and Liberia (Kaiser Daily HIV/AIDS Policy Report, 2/14).

Bush in his speech on Thursday said that one of the “major priorities” of his presidency has been to “fundamentally alte[r] our policy toward Africa,” adding, “Paternalism has got to be a thing of the past. Joint venturing with good, capable people is what the future is all about” (Baker, Washington Post, 2/15). He also sought to assure the African people that the U.S. “is committed to them today, tomorrow and long into their continent’s bright future,” according to the Los Angeles Times (Gerstenzang, Los Angeles Times, 2/15).

“We’ve seen that conditions on the other side of the world can have a direct impact on our own security,” Bush said, adding, “We know that if Africa were to continue on the old path of decline, it would be more likely to produce failed states, foster ideologies of radicalism and spread violence across borders” (Stolberg, New York Times, 2/15). In addition, Bush said, “Across Africa, people have begun to speak of the ‘Lazarus effect,’ where communities once given up for dead are coming back to life,” adding, “Some call this a remarkable success. I call it a good start.”

According to USA Today, some critics say the $30 billion Bush is requesting for the next five years of PEPFAR represents no increase from the current fiscal year’s funding level. Critics also object to a requirement that a portion of the program’s HIV/AIDS prevention funds be spent on abstinence education. Paul Zeitz, executive director of the Global AIDS Alliance, said the ideological approach to PEPFAR is “extremely flawed” and the fund insufficient (USA Today, 2/15).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2007 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

“2008 Presidential Candidate Issue Spotlight: Global Health and HIV/AIDS,” Kaiser Family Foundation: This issue spotlight, available at health08.org, provides brief summaries of each presidential candidate’s position on HIV/AIDS and global health, along with a selection of quotes and links to additional resources (Kaiser Family Foundation release, 2/14).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2007 Advisory Board Company and Kaiser Family Foundation. All rights reserved.